| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$143 |
Placement Settlement Completed
|
17 Apr 2025 10:34AM |
$0.290 |
$0.495 |
risen by
70.69%
|
|
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$143 |
Application for quotation of securities - RCE
|
17 Apr 2025 10:28AM |
$0.290 |
$0.495 |
risen by
70.69%
|
|
| Equity Story Group Ltd (EQS) ORDINARY FULLY PAID |
Financials |
- |
Investor Presentation - Expansion into Retail Broking
|
17 Apr 2025 10:25AM |
$0.035 |
$0.014 |
fallen by
60%
|
|
| Santos Limited (STO) ORDINARY FULLY PAID |
Energy |
$23,238 |
Change of Director's Interest Notice
|
17 Apr 2025 10:20AM |
$5.620 |
$7.155 |
risen by
27.31%
|
|
| Belararox Limited (BRX) ORDINARY FULLY PAID |
Materials |
$23 |
Initial Director's Interest Notice - Zuo
|
17 Apr 2025 10:19AM |
$0.140 |
$0.087 |
fallen by
37.86%
|
|
| Altech Batteries Limited (ATC) ORDINARY FULLY PAID |
Materials |
$67 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
17 Apr 2025 10:19AM |
$0.039 |
$0.025 |
fallen by
35.90%
|
|
ATC - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was negative at $3,057,000.
- Total cash and cash equivalents at the end of the quarter were $2,191,000.
- Altech is seeking additional funding through a Bond Note Subscription Deed.
- The company plans to sell land in Johor to raise funds.
- A General Meeting is scheduled for May 13, 2025, for shareholder approval.
- Quarterly activities report outlines cash flows for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Belararox Limited (BRX) ORDINARY FULLY PAID |
Materials |
$23 |
Final Director's Interest Notice - Ward
|
17 Apr 2025 10:19AM |
$0.140 |
$0.087 |
fallen by
37.86%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,993 |
Becoming a substantial holder from MUFG
|
17 Apr 2025 10:18AM |
$32.110 |
$19.270 |
fallen by
39.99%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$222 |
Lumos Secures Key US Reimbursement Milestones for FebriDx
|
17 Apr 2025 10:17AM |
$0.022 |
$0.280 |
risen by
1,172.73%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos has secured reimbursement coverage for FebriDx with two Medicare Administration Contractors.
- The reimbursement rate is set at US$41.38 per test effective April 2025.
- Medicare comprises 20%-24% of the U.S. reimbursement payor mix.
- Negotiations continue with the remaining five MACs.
- Medicare adoption often sets a precedent for private insurance payors.
- FebriDx is included in the 2025 Clinical Laboratory Fee Schedule under PLA Code #0442U.
- Lumos has engaged with all seven MACs and is seeing positive early momentum.
- Lumos expects that increasing Medicare adoption will influence private insurers to adopt coverage.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPM Minerals Limited (BPM) ORDINARY FULLY PAID |
Materials |
$38 |
Exploration Update - Claw Gold Project WA
|
17 Apr 2025 10:16AM |
$0.036 |
$0.295 |
risen by
719.44%
|
|
BPM - Price-sensitive ASX Announcement
Full Release
Key Points
- Assay results from an 84-hole, 3,647m aircore drilling program at the Claw Gold Project.
- Key intercepts included 2m @ 0.36 g/t Au and 1m @ 0.18 g/t Au.
- Significant prior results include 25m @ 1.27 g/t Au from the Louie Prospect.
- The Claw Project lies immediately south of Capricorn Metals' 3.99Moz Mount Gibson Gold Project.
- Upcoming soil sampling planned upon granting of new exploration tenure.
- BPM is reviewing new project opportunities in the precious metal space.
- The company has approximately $2m cash and 87.3m shares on issue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$6 |
Cancel - Proposed issue of securities - WHK
|
17 Apr 2025 10:15AM |
$0.013 |
$0.007 |
fallen by
46.15%
|
|
| Dusk Group Limited (DSK) ORDINARY FULLY PAID |
Consumer Discretionary |
$57 |
Appointment of Additional Company Secretary
|
17 Apr 2025 10:07AM |
$1.010 |
$0.915 |
fallen by
9.41%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,639 |
Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives
|
17 Apr 2025 10:07AM |
$1.600 |
$2.045 |
risen by
27.81%
|
|
| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$1,216 |
Notice of Annual General Meeting/Proxy Form
|
17 Apr 2025 10:03AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$7 |
Notice of Annual General Meeting/Proxy Form
|
17 Apr 2025 10:01AM |
$0.011 |
$0.016 |
risen by
45.45%
|
|
| Aureka Limited (AKA) ORDINARY FULLY PAID |
Materials |
$21 |
March 2025 Quarterly Activities & Cashflow Report
|
17 Apr 2025 9:58AM |
$0.130 |
$0.130 |
fallen by
0%
|
|
AKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Aureka Limited owns a portfolio of advanced stage high-grade gold projects across Victoria.
- The company has commenced a 7,000-meter drilling campaign across the Irvine and Tandarra projects.
- Diamond drilling at the Resolution Lode has started with promising results indicating potential mineral extensions.
- Strategic acquisition of 97 hectares surrounding the Irvine Project enhances operational certainty.
- The company's cash balance as of March 31, 2025, was $4.0 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$7 |
Appendix 4G and Corporate Governance Statement
|
17 Apr 2025 9:56AM |
$0.011 |
$0.016 |
risen by
45.45%
|
|
| DUG Technology Ltd (DUG) ORDINARY FULLY PAID |
Information Technology |
$278 |
Dr Fabio Mancini joins the DUG ranks
|
17 Apr 2025 9:56AM |
$0.900 |
$2.050 |
risen by
127.78%
|
|
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,265 |
Clarity signs commercial-scale copper-64 Supply Agreement
|
17 Apr 2025 9:55AM |
$1.680 |
$3.400 |
risen by
102.38%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity signed a commercial-scale supply agreement with Nusano for copper-64 isotopes.
- Nusano's facility can produce over 1,000 Ci of copper-64 per day.
- The agreement supports Clarity's late-stage clinical trials and commercial launch plans.
- Production of copper-64 to commence in early 2026.
- Nusano will also produce copper-67 and actinium-225 isotopes for Clarity's products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,265 |
$11.1 million RDTI and refocus on high-priority programs
|
17 Apr 2025 9:53AM |
$1.680 |
$3.400 |
risen by
102.38%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity received an $11,146,204 R&D Tax Incentive refund.
- This funding will support the further development of Clarity's Targeted Copper Theranostic platform.
- The company has approximately $106 million in cash for research and commercialization efforts.
- Clarity will prioritize the development of 64/67Cu-SAR-bisPSMA for prostate cancer applications.
- The development of SARTATE will focus on neuroendocrine tumors.
- The CL04 and COMBAT trials are being closed due to financial market turbulence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Burley Minerals Ltd (BUR) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - BUR
|
17 Apr 2025 9:53AM |
$0.044 |
$0.033 |
fallen by
25%
|
|
| Burley Minerals Ltd (BUR) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - BUR
|
17 Apr 2025 9:53AM |
$0.044 |
$0.033 |
fallen by
25%
|
|
| Burley Minerals Ltd (BUR) ORDINARY FULLY PAID |
Materials |
$6 |
Placement and Entitlement Offer to raise $1 million
|
17 Apr 2025 9:53AM |
$0.044 |
$0.033 |
fallen by
25%
|
|
BUR - Price-sensitive ASX Announcement
Full Release
Key Points
- $450,000 share placement and $563,000 non-renounceable entitlement offer announced.
- Funds will be used for drilling and exploration at the Cane Bore Iron Ore Project.
- Maiden drilling program expected to be completed in April 2025.
- Cane South Target covers over 800,000m2 with significant iron ore potential.
- Total of 5,000,000m2 identified as drilling targets since September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$7 |
Annual Report to shareholders
|
17 Apr 2025 9:52AM |
$0.011 |
$0.016 |
risen by
45.45%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,587 |
Appendix 3C
|
17 Apr 2025 9:50AM |
$47.690 |
$37.000 |
fallen by
22.42%
|
|